Log in to add personal notes on this page.
A newborn develops extensive blistering and skin erosions after minimal friction. Skin biopsy shows separation at the dermal-epidermal junction.
Heterogeneous; genes for the proteins that anchor the epidermis to the dermis. Disruption of each protein splits the skin at its own level:
- EB simplex: KRT5, KRT14 (keratin) - AD, intraepidermal
- Junctional EB: LAMA3, LAMB3, LAMC2, COL17A1 - AR, within lamina lucida
- Dystrophic EB: COL7A1 (type VII collagen) - AD or AR, sublamina densa
Basal keratinocytes hold to the dermis through a chain: the keratin network inside the cell, hemidesmosomes, the basement membrane, and anchoring fibrils below it. Each EB type disrupts a different link.
- EB simplex (KRT5, KRT14): keratins 5 and 14 pair and assemble into the filament network that gives basal cells their resistance to minor trauma. Dominant-negative missense variants predominate: the mutant keratin blocks normal pairing and assembly into filaments. Variants in the conserved ends of the rod domain, thought to be needed for filament assembly, tend to cause severe disease. Rare biallelic null variants cause recessive EBS.
- Junctional EB (LAMA3, LAMB3, LAMC2, COL17A1): the laminin genes make the three chains of laminin 332; COL17A1 makes collagen XVII, a hemidesmosome protein. Biallelic null variants in the laminin 332 genes usually cause the generalized severe form, while COL17A1 variants, null alleles included, typically cause intermediate disease. Missense and splice variants usually cause intermediate disease; residual functional protein appears to be what lessens severity.
- Dystrophic EB (COL7A1): collagen VII forms the anchoring fibrils. Recessive DEB usually follows absent collagen VII from null variants. Dominant DEB comes mostly from glycine substitutions in the triple helix that may disturb its coiling, a dominant-negative effect.
- Skin fragility with blistering from minimal trauma
- Severity varies from mild (localized EB simplex) to lethal (junctional EB, Herlitz type)
- Scarring (dystrophic forms)
- Mucosal involvement (severe forms)
- Squamous cell carcinoma risk (recessive dystrophic EB)
- Skin biopsy of an induced fresh blister with immunofluorescence antigen mapping to localize the cleavage plane (intraepidermal vs lamina lucida vs sublamina densa)
- Transmission electron microscopy as an adjunct to define the level of separation
- Molecular gene-panel testing (KRT5, KRT14, LAMA3, LAMB3, LAMC2, COL17A1, COL7A1) to confirm subtype and guide prognosis and counseling
- No curative therapy; multidisciplinary supportive care (dermatology, nutrition, pain, wound care nursing)
- Atraumatic wound care: non-adherent dressings, blister lancing, and infection surveillance with treatment of secondary infection
- Nutritional support and management of strictures, anemia, and contractures in severe forms
- Recessive dystrophic EB: routine surveillance for cutaneous squamous cell carcinoma